Form 4: Elanco Animal Health Executive Acquires Deferred Stock Units

Jose Manuel Correia de Simas, an Executive Vice President at Elanco Animal Health, acquired deferred stock units representing the right to receive common stock or cash equivalent.

Summary

• On March 7, 2025, Jose Manuel Correia de Simas, an Executive Vice President at Elanco Animal Health Inc., acquired 4,642.6284 deferred stock units.
• Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent.
• These deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.
• The price of the derivative security is $11.14.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing an executive's compensation. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the compensation and equity ownership of company executives.

Key Dates